Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Agex Therapeutics Inc (AGE)
Agex Therapeutics Inc (AGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,006
  • Shares Outstanding, K 37,951
  • Annual Sales, $ 30 K
  • Annual Income, $ -10,460 K
  • 60-Month Beta 1.50
  • Price/Sales 524.95
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AGE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.29
  • Most Recent Earnings -0.09 on 05/12/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3720 +20.46%
on 05/18/23
0.6300 -28.87%
on 05/03/23
-0.1851 (-29.23%)
since 04/26/23
3-Month
0.3720 +20.46%
on 05/18/23
0.6900 -35.06%
on 04/11/23
-0.1501 (-25.09%)
since 02/24/23
52-Week
0.3720 +20.46%
on 05/18/23
0.8399 -46.65%
on 01/17/23
-0.2519 (-35.99%)
since 05/26/22

Most Recent Stories

More News
AgeX Therapeutics Receives Stock Exchange Deficiency Letter

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on April 20, 2023 it received a letter...

AGE : 0.4481 (-4.72%)
AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter...

AGE : 0.4481 (-4.72%)
AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

AgeX Therapeutics , Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on November 22, 2022 it received notification...

AGE : 0.4481 (-4.72%)
AgeX Therapeutics Reports Third Quarter 2022 Financial Results

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter...

AGE : 0.4481 (-4.72%)
AgeX Therapeutics Reports Second Quarter 2022 Financial Results

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter...

AGE : 0.4481 (-4.72%)
Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that Dr. Joanne Hackett has been appointed Chairperson...

AGE : 0.4481 (-4.72%)
AgeX Therapeutics Reports First Quarter 2022 Financial Results

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter...

AGE : 0.4481 (-4.72%)
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter...

AGE : 0.4481 (-4.72%)
AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today a research collaboration with the...

AGE : 0.4481 (-4.72%)
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today that ImStem Biotechnology, Inc. (“ImStem”),...

AGE : 0.4481 (-4.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

AgeX Therapeutics Inc. is involved in the development and commercialization of novel therapeutics targeting human aging. The company's proprietary technology consists of PureStem(R) and Tissue Regeneration(TM). Its product pipeline includes AGEX-VASC1, AGEX-BAT1, AGEX-iTR1547 and Renelon(TM). AgeX Therapeutics...

See More

Key Turning Points

3rd Resistance Point 0.5025
2nd Resistance Point 0.4902
1st Resistance Point 0.4691
Last Price 0.4481
1st Support Level 0.4357
2nd Support Level 0.4234
3rd Support Level 0.4023

See More

52-Week High 0.8399
Fibonacci 61.8% 0.6612
Fibonacci 50% 0.6059
Fibonacci 38.2% 0.5507
Last Price 0.4481
52-Week Low 0.3720

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar